ABOUT
Company Profile
Founded in 2019, Calgent Biotechnology develops innovative oncology and immunology therapies that address unmet medical needs.
Our integrated R&D platform covering translational research, pharmacology, formulation, and clinical development accelerates drug discovery and development.
We combine proprietary programs with strategic in-licensing to build a robust pipeline and foster collaborative partnerships.
Guided by our core values of innovation, precision, and efficiency, we are committed to delivering transformative treatments with a long-term focus on age-related diseases and healthy aging.
Management Team
Chair of Board
Dr. Yun Yen MD, PhD
Education
- Taipei Med University (MD)
- Thomas Jefferson University (PhD)
- Yale University School of Medicine (Hem Onc Fellow)
Career Experience
- Over 40 years in translational medicine, oncology, and clinical practice
- Inventor on 80+ patents and author of over 400 scientific publications
- Held senior leadership roles including President of Taipei Medical University and Deputy Director at City of Hope National Medical Center
- Adjunct/Affiliate appointments at Caltech, Case Western Reserve University, Taipei Medical University, and Academia Sinica
- Fellow of the U.S. National Academy of Inventors
- Chair, Biomedical Division, Advanced Technology Advisory Committee, Industrial Technology Research Institute
- Member, Biotechnology Industry Strategy Advisory Committee
- Board Member, National Health Research Institutes and Tzu Chi Medical Foundation
CEO
Hui Wen Huang
Education
- E.M.B.A., Business Administration, National Taiwan University
Career Experience
- Over 25 years of executive leadership in the biomedical industry, spanning drug development, medical devices, healthcare management, and CRO operations
- Extensive expertise in regulatory strategy, IP, market analysis, and commercial valuation
- Former Director of Business Development at Taipei Medical University and General Manager of affiliated healthcare and pharmaceutical companies
- Senior leadership roles in CRO and pharmaceutical marketing
- Advisor to government agencies and national biotech parks on policy and strategic review
Independent Director at Lightek Corporation
Chief Financial Officer of Finance Dept.
Sherry Dai
Education
- M.S., Business Administration, National Taipei University
Career Experience
- Over 25 years of financial management experience, including 20+ years in high-tech industries such as semiconductors, solar energy, and medical devices
- Former Chief Financial Officer and corporate spokesperson for publicly listed companies, successfully leading IPOs and OTC market entries
- Skilled in financial systems, internal controls, investor relations, and HR administration
- Certified executive for publicly listed companies
Director of Business Development Dept.
Jenny Jang
Education
- M.S., Nutrition, Pennsylvania State University, USA
- M.S., Institute of Microbiology & Biochemistry, National Taiwan University
- B.S., Biochemical Science and Technology, National Taiwan University
Career Experience
- Over 20 years of business development experience in the biomedical sector
- Former Director of Business Development at Tanvex BioPharm, Head of Commercialization at Development Center for Biotechnology
- Held senior management roles at pharma and biotech companies including Gold NanoTech, Global Investment Holdings, NatureWise, and Orient EuroPharma
Director of Clinical Research & Operation Dept.
Jing Yi Lee
Education
- Ph.D. in PharmacologySchool, National Yang-Ming University
Career Experience
- Over 11 years of experience in small molecule drug development for metabolic, dermatological, rare diseases, and oncology indications
- Experienced in clinical and non-clinical research, CRO management, and project oversight
- Led design and execution of Phase I/II clinical trials and key toxicology study audits
- Former Scientific Expert at Paraxel International and Associate Director of Medical Research at TWi Biotechnology
Director of CMC & Formulation Dept.
Yu Tsai Yang
Education
- Ph.D., School of Dentistry-Master and PhD Program, Taipei Medical University
Career Experience
- Over 16 years hands-on experience in formulation development, drug delivery technologies, and process development
- Specializes in oral delivery platforms for protein therapeutics; holder of multiple international patents
- Former Director of Drug Development at Innopharmax
- Post-doctoral Fellow, School of Pharmacy, University of North Carolina at Chapel Hill, USA
Director of Translational Research Dept.
MingZi Zhang
Education
- Ph.D., Chemical Biology, Rockefeller University
- B.Sc., Bacteriology, University of Wisconsin-Madison
Career Experience
- Over 10 years of interdisciplinary research experience bridging chemistry and biology in biomedical science
- Associate Investigator at Institute of Molecular and Genomic Medicine, National Health Research Institutes
- Former Agency for Science Technology and Research (A*STAR) Scientist
Scientific Advisory Board
Robert B. Diasio, M.D.
Mayo Clinic Cancer Center
James Mulé, PhD
Moffitt Cancer Center
Jacqueline Whang-Peng, M.D., Ph.D.
Academician, Academia Sinica, ROC
Robert B. Diasio, M.D.
Mayo Clinic Cancer Center
James Mulé, PhD
Moffitt Cancer Center
Jacqueline Whang-Peng, M.D., Ph.D.
Academician, Academia Sinica, ROC